Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study.

Foulon S, Cony-Makhoul P, Guerci-Bresler A, Delord M, Solary E, Monnereau A, Bonastre J, Tubert-Bitter P.

Cancer Med. 2019 Jun;8(6):3296-3304. doi: 10.1002/cam4.2200. Epub 2019 Apr 30.

2.

Short-Term Risk of Aortoiliac Aneurysm or Dissection Associated With Fluoroquinolone Use.

Maumus-Robert S, Bérard X, Mansiaux Y, Tubert-Bitter P, Debette S, Pariente A.

J Am Coll Cardiol. 2019 Feb 26;73(7):875-877. doi: 10.1016/j.jacc.2018.12.012. No abstract available.

PMID:
30784681
3.

Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database.

Courtois É, Pariente A, Salvo F, Volatier É, Tubert-Bitter P, Ahmed I.

Front Pharmacol. 2018 Sep 18;9:1010. doi: 10.3389/fphar.2018.01010. eCollection 2018.

4.

Instrumental variable analysis in the context of dichotomous outcome and exposure with a numerical experiment in pharmacoepidemiology.

Koladjo BF, Escolano S, Tubert-Bitter P.

BMC Med Res Methodol. 2018 Jun 22;18(1):61. doi: 10.1186/s12874-018-0513-y.

5.

A benefit-risk analysis of rotavirus vaccination, France, 2015.

Lamrani A, Tubert-Bitter P, Hill C, Escolano S.

Euro Surveill. 2017 Dec;22(50). doi: 10.2807/1560-7917.ES.2017.22.50.17-00041.

6.

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

Demailly R, Escolano S, Quantin C, Tubert-Bitter P, Ahmed I.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1126-1134. doi: 10.1002/pds.4265. Epub 2017 Jul 30.

PMID:
28758270
7.

Bayesian model selection in logistic regression for the detection of adverse drug reactions.

Marbac M, Tubert-Bitter P, Sedki M.

Biom J. 2016 Nov;58(6):1376-1389. doi: 10.1002/bimj.201500098. Epub 2016 May 25.

PMID:
27225325
8.

Genes Interacting with Occupational Exposures to Low Molecular Weight Agents and Irritants on Adult-Onset Asthma in Three European Studies.

Rava M, Ahmed I, Kogevinas M, Le Moual N, Bouzigon E, Curjuric I, Dizier MH, Dumas O, Gonzalez JR, Imboden M, Mehta AJ, Tubert-Bitter P, Zock JP, Jarvis D, Probst-Hensch NM, Demenais F, Nadif R.

Environ Health Perspect. 2017 Feb;125(2):207-214. doi: 10.1289/EHP376. Epub 2016 Aug 9.

9.

Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.

Canonico M, Carcaillon L, Plu-Bureau G, Oger E, Singh-Manoux A, Tubert-Bitter P, Elbaz A, Scarabin PY.

Stroke. 2016 Jul;47(7):1734-41. doi: 10.1161/STROKEAHA.116.013052. Epub 2016 Jun 2.

10.

Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions.

Ahmed I, Pariente A, Tubert-Bitter P.

Stat Methods Med Res. 2018 Mar;27(3):785-797. doi: 10.1177/0962280216643116. Epub 2016 Apr 25.

PMID:
27114328
11.

A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases.

Arnaud M, Salvo F, Ahmed I, Robinson P, Moore N, Bégaud B, Tubert-Bitter P, Pariente A.

Drug Saf. 2016 Mar;39(3):251-60. doi: 10.1007/s40264-015-0375-8.

PMID:
26715499
12.

Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.

Briand V, Escolano S, Journot V, Massougbodji A, Cot M, Tubert-Bitter P.

Am J Trop Med Hyg. 2015 Aug;93(2):300-4. doi: 10.4269/ajtmh.14-0783. Epub 2015 Jun 8.

13.

Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.

Escolano S, Hill C, Tubert-Bitter P.

Vaccine. 2015 Feb 18;33(8):1017-20. doi: 10.1016/j.vaccine.2015.01.005. Epub 2015 Jan 14.

PMID:
25596460
14.

Matching methods to create paired survival data based on an exposure occurring over time: a simulation study with application to breast cancer.

Savignoni A, Giard C, Tubert-Bitter P, Rycke YD.

BMC Med Res Methodol. 2014 Jun 26;14:83. doi: 10.1186/1471-2288-14-83.

15.

Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases.

Leroy F, Dauxois JY, Théophile H, Haramburu F, Tubert-Bitter P.

BMC Med Res Methodol. 2014 Feb 3;14:17. doi: 10.1186/1471-2288-14-17.

16.

Dynamics of the risk of smoking-induced lung cancer: a compartmental hidden Markov model for longitudinal analysis.

Chadeau-Hyam M, Tubert-Bitter P, Guihenneuc-Jouyaux C, Campanella G, Richardson S, Vermeulen R, De Iorio M, Galea S, Vineis P.

Epidemiology. 2014 Jan;25(1):28-34. doi: 10.1097/EDE.0000000000000032.

PMID:
24240650
17.

Global determinants of mortality in under 5s: 10 year worldwide longitudinal study.

Hanf M, Nacher M, Guihenneuc C, Tubert-Bitter P, Chavance M.

BMJ. 2013 Nov 8;347:f6427. doi: 10.1136/bmj.f6427.

18.

Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/mumps/rubella immunization.

Hanf M, Quantin C, Farrington P, Benzenine E, Hocine NM, Velten M, Tubert-Bitter P, Escolano S.

Vaccine. 2013 Dec 2;31(49):5856-62. doi: 10.1016/j.vaccine.2013.09.052. Epub 2013 Oct 14.

PMID:
24135575
19.

Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology.

Quantin C, Benzenine E, Velten M, Huet F, Farrington CP, Tubert-Bitter P.

Am J Epidemiol. 2013 Dec 15;178(12):1731-9. doi: 10.1093/aje/kwt207. Epub 2013 Sep 27.

PMID:
24077093
20.

A new self-controlled case series method for analyzing spontaneous reports of adverse events after vaccination.

Escolano S, Hill C, Tubert-Bitter P.

Am J Epidemiol. 2013 Nov 1;178(9):1496-504. doi: 10.1093/aje/kwt128. Epub 2013 Sep 7.

PMID:
24013203
21.

Drugs induced pulmonary arterial hypertension.

Seferian A, Chaumais MC, Savale L, Günther S, Tubert-Bitter P, Humbert M, Montani D.

Presse Med. 2013 Sep;42(9 Pt 2):e303-10. doi: 10.1016/j.lpm.2013.07.005. Epub 2013 Aug 22. Review.

PMID:
23972547
22.

Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X, d'Ortho MP, Launois S, Lignot S, Bourgin P, Nogues B, Rey M, Bayard S, Scholz S, Lavault S, Tubert-Bitter P, Saussier C, Pariente A; Narcoflu-VF study group.

Brain. 2013 Aug;136(Pt 8):2486-96. doi: 10.1093/brain/awt187.

PMID:
23884811
23.

Selection of genes for gene-environment interaction studies: a candidate pathway-based strategy using asthma as an example.

Rava M, Ahmed I, Demenais F, Sanchez M, Tubert-Bitter P, Nadif R.

Environ Health. 2013 Jul 3;12:56. doi: 10.1186/1476-069X-12-56.

24.

Temporal asthma patterns using repeated questionnaires over 13 years in a large French cohort of women.

Sanchez M, Bousquet J, Le Moual N, Jacquemin B, Clavel-Chapelon F, Humbert M, Kauffmann F, Tubert-Bitter P, Varraso R.

PLoS One. 2013 May 31;8(5):e65090. doi: 10.1371/journal.pone.0065090. Print 2013.

25.

Comparison of two drug safety signals in a pharmacovigilance data mining framework.

Tubert-Bitter P, Bégaud B, Ahmed I.

Stat Methods Med Res. 2016 Apr;25(2):615-29. doi: 10.1177/0962280212462295. Epub 2012 Oct 14.

PMID:
23070598
26.

Effect of an event occurring over time and confounded by health status: estimation and interpretation. A study based on survival data simulations with application on breast cancer.

Savignoni A, Hajage D, Tubert-Bitter P, De Rycke Y.

Stat Med. 2012 Dec 30;31(30):4444-55. doi: 10.1002/sim.5631. Epub 2012 Sep 24.

PMID:
23007695
27.

Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.

Ahmed I, Thiessard F, Miremont-Salamé G, Haramburu F, Kreft-Jais C, Bégaud B, Tubert-Bitter P.

Drug Saf. 2012 Jun 1;35(6):495-506. doi: 10.2165/11597180-000000000-00000.

PMID:
22612853
28.

Pulmonary hypertension associated with benfluorex exposure.

Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jaïs X, Montani D, Sitbon O, Simonneau G, Humbert M.

Eur Respir J. 2012 Nov;40(5):1164-72. doi: 10.1183/09031936.00188611. Epub 2012 Apr 20.

29.

Pulmonary arterial hypertension in patients treated by dasatinib.

Montani D, Bergot E, Günther S, Savale L, Bergeron A, Bourdin A, Bouvaist H, Canuet M, Pison C, Macro M, Poubeau P, Girerd B, Natali D, Guignabert C, Perros F, O'Callaghan DS, Jaïs X, Tubert-Bitter P, Zalcman G, Sitbon O, Simonneau G, Humbert M.

Circulation. 2012 May 1;125(17):2128-37. doi: 10.1161/CIRCULATIONAHA.111.079921. Epub 2012 Mar 26.

PMID:
22451584
30.

Intussusception after rotavirus vaccination--spontaneous reports.

Escolano S, Farrington CP, Hill C, Tubert-Bitter P.

N Engl J Med. 2011 Dec 1;365(22):2139. doi: 10.1056/NEJMc1107771. No abstract available.

31.

How a new stratified adaptive phase II design could improve targeting population.

Tournoux-Facon C, De Rycke Y, Tubert-Bitter P.

Stat Med. 2011 Jun 15;30(13):1555-62. doi: 10.1002/sim.4211. Epub 2011 Mar 22.

PMID:
21432892
32.

Targeting population entering phase III trials: a new stratified adaptive phase II design.

Tournoux-Facon C, De Rycke Y, Tubert-Bitter P.

Stat Med. 2011 Apr 15;30(8):801-11. doi: 10.1002/sim.4148. Epub 2011 Jan 12.

PMID:
21432875
33.

Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study.

Ahmed I, Thiessard F, Miremont-Salamé G, Bégaud B, Tubert-Bitter P.

Clin Pharmacol Ther. 2010 Oct;88(4):492-8. doi: 10.1038/clpt.2010.111. Epub 2010 Sep 1.

PMID:
20811349
34.

False discovery rate estimation for frequentist pharmacovigilance signal detection methods.

Ahmed I, Dalmasso C, Haramburu F, Thiessard F, Broët P, Tubert-Bitter P.

Biometrics. 2010 Mar;66(1):301-9. doi: 10.1111/j.1541-0420.2009.01262.x. Epub 2009 May 4.

PMID:
19432790
35.

Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.

Ahmed I, Haramburu F, Fourrier-Réglat A, Thiessard F, Kreft-Jais C, Miremont-Salamé G, Bégaud B, Tubert-Bitter P.

Stat Med. 2009 Jun 15;28(13):1774-92. doi: 10.1002/sim.3586.

PMID:
19360795
36.

[Treatment of information on personal health data for research purposes: nobody should ignore the law].

Bonaïti-Pellié C, Arveux P, Billette de Villemeur A, Dantchev N, Elbaz A, Fabre-Guillevin E, Fresson J, Saura C, Saurel-Cubizolles MJ, Serre JL, Simon D, Stucker I, Thélot B, Tubert-Bitter P, Zureik M.

Med Sci (Paris). 2009 Jan;25(1):93-7. doi: 10.1051/medsci/200925193. French. No abstract available.

37.

Monitoring vaccine safety using case series cumulative sum charts.

Musonda P, Hocine MN, Andrews NJ, Tubert-Bitter P, Farrington CP.

Vaccine. 2008 Oct 3;26(42):5358-67. doi: 10.1016/j.vaccine.2008.08.010. Epub 2008 Aug 22.

PMID:
18723063
38.

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.

Canonico M, Olié V, Carcaillon L, Tubert-Bitter P, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group.

Thromb Haemost. 2008 Jan;99(1):246-8. doi: 10.1160/TH07-09-0536. No abstract available.

PMID:
18217166
39.
40.

Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.

Hocine MN, Farrington CP, Touzé E, Whitaker HJ, Fourrier A, Moreau T, Tubert-Bitter P.

Vaccine. 2007 Aug 1;25(31):5938-43. Epub 2007 Jun 8.

PMID:
17597263
41.

Relative-risk ratio was a useful measure of differential association in cohort and case-series studies.

Hocine MN, Tubert-Bitter P, Moreau T, Chavance M, Varon E, Guillemot D.

J Clin Epidemiol. 2007 Apr;60(4):361-5. Epub 2007 Jan 22.

PMID:
17346610
42.

A combined superiority and non-inferiority approach to multiple endpoints in clinical trials.

Bloch DA, Lai TL, Su Z, Tubert-Bitter P.

Stat Med. 2007 Mar 15;26(6):1193-207.

PMID:
16791905
43.

Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance.

Roux E, Thiessard F, Fourrier A, Bégaud B, Tubert-Bitter P.

IEEE Trans Inf Technol Biomed. 2005 Dec;9(4):518-27.

PMID:
16379369
44.

Testing independence between two Poisson-generated multinomial variables in case-series and cohort studies.

Hocine M, Guillemot D, Tubert-Bitter P, Moreau T.

Stat Med. 2005 Dec 30;24(24):4035-44.

PMID:
16320271
45.

Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

Thiessard F, Roux E, Miremont-Salamé G, Fourrier-Réglat A, Haramburu F, Tubert-Bitter P, Bégaud B.

Drug Saf. 2005;28(8):731-40.

PMID:
16048358
46.

An easy to use method to approximate Poisson confidence limits.

Bégaud B, Martin K, Abouelfath A, Tubert-Bitter P, Moore N, Moride Y.

Eur J Epidemiol. 2005;20(3):213-6.

PMID:
15921037
47.

A nonparametric comparison of the effectiveness of treatments: a multivariate toxicity-penalized approach.

Tubert-Bitter P, Letierce A, Bloch DA, Kramar A.

J Biopharm Stat. 2005;15(1):129-42.

PMID:
15702609
48.

Spontaneous reporting of adverse drug reactions: who reports and what?

Tubert-Bitter P, Haramburu F, Begaud B, Chaslerie A, Abraham E, Hagry C.

Pharmacoepidemiol Drug Saf. 1998 Sep;7(5):323-9.

PMID:
15073979
49.

A simple method to estimate sample sizes for safety equivalence studies using inverse sampling.

Moore N, Tubert-Bitter P, Fourrier A, Bégaud B.

J Clin Epidemiol. 2003 May;56(5):433-5.

PMID:
12812816
50.

Supplemental Content

Loading ...
Support Center